Related Experiment Video
Updated: May 8, 2025
08:47
Rapid Viscoelastic Characterization of Airway Mucus Using a Benchtop Rheometer
Published on: April 21, 2022
3.1K
Mucins and Their Roles in Asthma
Qihua Ye1,2, Gilda Opoku1,3, Marika Orlov1
1Division of Pulmonary Science and Critical Care Medicine, University of Colorado School of Medicine, Denver, Colorado, USA.
Immunological Reviews
|April 30, 2025
Summary
Mucus, essential for airway defense, relies on regulated mucins MUC5AC and MUC5B. Understanding their regulation in healthy and asthmatic lungs may reveal new treatments for mucus dysfunction.
Area of Science:
- Pulmonary Medicine
- Cell Biology
- Biochemistry
Background:
- Mucus is vital for airway host defense, with mucins MUC5AC and MUC5B as key components.
- Optimal mucin function requires tight regulation of gene expression, protein synthesis, and secretion.
- Abnormal mucus production is a significant clinical issue in asthma, often targeted by current therapies.
Purpose of the Study:
- To review the regulation of mucin gene expression, protein synthesis, and secretion.
- To compare these regulatory processes in healthy versus asthmatic lungs.
- To identify potential targets for novel therapeutic interventions for airway mucus dysfunction.
Main Methods:
- Literature review of existing research on mucin biology.
- Analysis of studies focusing on mucin regulation in respiratory diseases.
- Synthesis of information on cellular and molecular mechanisms governing mucin production and secretion.
Main Results:
- Mucin expression is localized to specific secretory epithelial cells.
- Regulation of mucin production and secretion is complex, involving multiple cellular pathways.
- Asthma is characterized by aberrant mucus production, highlighting dysregulation in these processes.
Conclusions:
- A comprehensive understanding of mucin regulation is crucial for addressing airway mucus dysfunction.
- Further research into these mechanisms could lead to innovative strategies for preventing or reversing mucus-related lung diseases.
- Targeting mucin regulation offers potential for new therapeutic approaches in asthma and other conditions.
Related Concept Videos
01:20Asthma: Pathogenesis and Management
224
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
224
01:26Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
01:29Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
01:20Antiasthma Drugs: Muscarinic Receptor Antagonists
130
Muscarinic receptor antagonists, also known as antimuscarinic agents, are a class of bronchodilators used to treat asthma, although they are more commonly used to treat COPD. They work by inhibiting the action of acetylcholine (ACh), a neurotransmitter, on muscarinic receptors found in the airways.
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
130
01:16Drugs Used in Upper Respiratory Disorders: Overview
129
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
129
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
151
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
151